Enzo Biochem (ENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENZ | AMGN | REGN | VRTX | GSK |
| Company | Enzo Biochem | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.0300 | 306.42 | 984.04 | 451.90 | 45.42 |
| High | 1.0800 | 307.50 | 995.41 | 457.66 | 45.45 |
| Low | 1.0300 | 303.90 | 983.16 | 449.42 | 45.03 |
| Last | 1.0700 | 305.84 | 985.02 | 456.95 | 45.12 |
| Change | +0.0200 | -0.66 | +4.45 | +6.15 | -0.03 |
| % Change | +1.90% | -0.22% | +0.45% | +1.36% | -0.07% |
| Volume | 50,500 | 2,425,800 | 259,200 | 1,050,800 | 2,210,200 |
| 20-Day Average Volume | 99,645 | 2,868,870 | 425,045 | 1,162,310 | 3,931,540 |
| Previous Close | 1.0500 | 306.50 | 980.57 | 450.80 | 45.15 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0700 | 303.24 | 961.40 | 424.54 | 44.27 |
| 20-Day Raw Stochastic | 53.62% | 68.74% | 88.79% | 98.92% | 82.13% |
| 20-Day Relative Strength | 43.70% | 57.73% | 59.92% | 74.37% | 62.21% |
| Weighted Alpha | -46.55 | +36.96 | +35.05 | +40.81 | +35.22 |
| Today's Opinion | 96% Sell | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 72% Sell | 8% Buy | 8% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.83% since 05/17/24 | -2.12% since 05/17/24 | +0.28% since 05/17/24 | +2.64% since 05/17/24 | +0.31% since 05/17/24 |
| Low | 1.0300 on 05/24/24 | 303.90 on 05/24/24 | 975.73 on 05/23/24 | 437.46 on 05/21/24 | 44.40 on 05/20/24 |
| High | 1.1299 on 05/20/24 | 316.67 on 05/21/24 | 997.87 on 05/22/24 | 457.66 on 05/24/24 | 45.79 on 05/22/24 |
| 1-Month | |||||
| %Chg | +0.94% since 04/24/24 | +12.03% since 04/24/24 | +8.66% since 04/24/24 | +14.02% since 04/24/24 | +10.43% since 04/24/24 |
| Low | 0.9901 on 05/06/24 | 265.72 on 04/26/24 | 875.22 on 04/26/24 | 391.70 on 04/30/24 | 40.81 on 04/25/24 |
| High | 1.1391 on 05/16/24 | 322.60 on 05/03/24 | 997.87 on 05/22/24 | 457.66 on 05/24/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -22.46% since 02/23/24 | +5.76% since 02/23/24 | +0.39% since 02/23/24 | +6.24% since 02/23/24 | +6.87% since 02/23/24 |
| Low | 0.9901 on 05/06/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 39.15 on 04/18/24 |
| High | 1.4000 on 02/26/24 | 322.60 on 05/03/24 | 998.33 on 02/28/24 | 457.66 on 05/24/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -16.41% since 11/24/23 | +15.21% since 11/24/23 | +23.39% since 11/24/23 | +29.43% since 11/24/23 | +26.00% since 11/24/23 |
| Low | 0.9901 on 05/06/24 | 260.68 on 04/19/24 | 792.57 on 11/28/23 | 346.29 on 11/28/23 | 35.35 on 11/29/23 |
| High | 1.5000 on 01/03/24 | 329.72 on 02/05/24 | 998.33 on 02/28/24 | 457.66 on 05/24/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 53,787 | 164,417,328 | 108,045,080 | 116,330,288 | 93,570,672 |
| Shares Outstanding, K | 51,226 | 536,435 | 110,186 | 258,053 | 2,072,440 |
| Annual Sales | 31,060,000 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 37,725,000,000 |
| Annual Net Income | 20,290,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 6,129,940,000 |
| Last Quarter Sales | 8,550,000 | 7,447,000,000 | 3,145,000,000 | 2,690,600,000 | 9,337,020,000 |
| Last Quarter Net Income | -3,060,000 | -113,000,000 | 722,000,000 | 1,099,600,000 | 1,326,430,000 |
| 60-Month Beta | 0.75 | 0.60 | 0.17 | 0.39 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 03/13/24 | 3.96 on 05/02/24 | 9.55 on 05/02/24 | 4.76 on 05/06/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 06/12/24 | 05/02/24 | 05/02/24 | 05/06/24 | 05/01/24 |
| Most Recent Dividend | 0.063 on 06/29/95 | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.61 | 26.51 | 29.72 | 11.33 |